Literature DB >> 25801686

Multiple sclerosis and HIV-1 infection: case report of a HIV controller.

Jerome H Chin1.   

Abstract

Multiple sclerosis (MS) has been infrequently described in association with human immunodeficiency virus (HIV) infection. Underreporting, missed diagnoses or a true negative association between MS and HIV infection are all possible explanations for the paucity of published cases. Since MS involves inflammation and demyelination of the central nervous system by autoreactive T cells, immunosuppression caused by HIV infection would be expected to confer a reduced risk of MS. This report describes a case of relapsing-remitting MS in a woman with non-progressive HIV-1 infection for 5 years. The patient has stable normal CD4+ cell counts and a low viral load in the absence of combination antitretroviral treatment (cART). She experienced typical neurological symptoms of MS including optic neuritis, trigeminal neuralgia, and transverse myelitis. MRI of the spinal cord demonstrated multiple lesions on T2-weighted images. Immune mechanisms associated with HIV control that may have contributed to the development and relapses of MS in this patient are discussed.

Entities:  

Mesh:

Year:  2015        PMID: 25801686     DOI: 10.1007/s13365-015-0335-1

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  14 in total

1.  Could antiretroviral drugs be effective in multiple sclerosis? A case report.

Authors:  H Maruszak; B J Brew; G Giovannoni; J Gold
Journal:  Eur J Neurol       Date:  2011-09       Impact factor: 6.089

2.  Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man.

Authors:  Joshua Chalkley; Joseph R Berger
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

3.  Neuromyelitis optica in patients with coexisting human immunodeficiency virus infections.

Authors:  Anteneh M Feyissa; Parbhdeep Singh; Robert G Smith
Journal:  Mult Scler       Date:  2013-04-02       Impact factor: 6.312

Review 4.  T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  J M Fletcher; S J Lalor; C M Sweeney; N Tubridy; K H G Mills
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

5.  Multiple sclerosis typical clinical and MRI findings in a patient with HIV infection.

Authors:  Alejandra González-Duarte; Carlos Ramirez; Ricardo Pinales; Juan Sierra-Madero
Journal:  J Neurovirol       Date:  2011-10-01       Impact factor: 2.643

Review 6.  CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review.

Authors:  Silvia R Delgado; Janice Maldonado; Kottil W Rammohan
Journal:  J Neurovirol       Date:  2014-07-01       Impact factor: 2.643

Review 7.  Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression.

Authors:  Kate Poropatich; David J Sullivan
Journal:  J Gen Virol       Date:  2010-11-24       Impact factor: 3.891

8.  Multiple sclerosis-like illness occurring with human immunodeficiency virus infection.

Authors:  J R Berger; W A Sheremata; L Resnick; S Atherton; M A Fletcher; M Norenberg
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

9.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

10.  Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors.

Authors:  Julie C Gaardbo; Hans J Hartling; Jan Gerstoft; Susanne D Nielsen
Journal:  AIDS Res Treat       Date:  2012-05-27
View more
  12 in total

1.  HIV immunodynamics and multiple sclerosis.

Authors:  Cieron Roe
Journal:  J Neurovirol       Date:  2015-09-25       Impact factor: 2.643

2.  HIV and decreased risk of multiple sclerosis: role of low CD4+ lymphocyte count and male prevalence.

Authors:  Tatiana Koudriavtseva; Domenico Plantone; Chiara Mandoj; Diana Giannarelli; Alessandra Latini; Manuela Colafigli; Elisabetta Trento; Paola Cordiali-Fei; Fulvia Pimpinelli
Journal:  J Neurovirol       Date:  2016-07-18       Impact factor: 2.643

3.  A survey of endogenous retrovirus (ERV) sequences in the vicinity of multiple sclerosis (MS)-associated single nucleotide polymorphisms (SNPs).

Authors:  Christine Brütting; Alexander Emmer; Malte Kornhuber; Martin S Staege
Journal:  Mol Biol Rep       Date:  2016-05-12       Impact factor: 2.316

Review 4.  Multiple Sclerosis and Subsequent Human Immunodeficiency Virus Infection: A Case with the Rare Comorbidity, Focus on Novel Treatment Issues and Review of the Literature.

Authors:  Charalampos Skarlis; Maria Gontika; Serafeim Katsavos; Giorgios Velonakis; Panagiotis Toulas; Maria Anagnostouli
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

5.  HIV infection and multiple sclerosis: a case with unexpected "no evidence of disease activity" status.

Authors:  Fernando Labella; Fernando Acebrón; María Del Carmen Blanco-Valero; Alba Rodrígez-Martín; Ángela Monterde Ortega; Eduardo Agüera Morales
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

6.  Down-regulation of interleukin 7 receptor (IL-7R) contributes to central nervous system demyelination.

Authors:  Xudan Lei; Shijiao Cai; Yang Chen; Jianlin Cui; Yajie Wang; Zongjin Li; Yuhao Li
Journal:  Oncotarget       Date:  2017-04-25

Review 7.  Cooccurrences of Putative Endogenous Retrovirus-Associated Diseases.

Authors:  Christine Brütting; Alexander Emmer; Malte E Kornhuber; Martin S Staege
Journal:  Biomed Res Int       Date:  2017-02-23       Impact factor: 3.411

8.  Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?

Authors:  Elena Morandi; Radu Tanasescu; Rachael E Tarlinton; Dumitru Constantin-Teodosiu; Bruno Gran
Journal:  Front Immunol       Date:  2019-01-22       Impact factor: 7.561

Review 9.  Viruses and endogenous retroviruses in multiple sclerosis: From correlation to causation.

Authors:  A-F A Mentis; E Dardiotis; N Grigoriadis; E Petinaki; G M Hadjigeorgiou
Journal:  Acta Neurol Scand       Date:  2017-05-23       Impact factor: 3.209

Review 10.  Two endogenous retroviral loci appear to contribute to Multiple Sclerosis.

Authors:  Bjørn A Nexø; Sara B Jensen; Kari K Nissen; Bettina Hansen; Magdalena J Laska
Journal:  BMC Neurol       Date:  2016-04-30       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.